Fund Takes Million Position in Boston Properties Stock
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
Assess which is better for you: index funds or active funds, focusing on costs, performance consistency, and your investment horizon.
24,613 articlesA major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
A major investment manager disclosed a sizable share disposal in a U.S. utility stock through an SEC filing. The move...
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
Institutional funds often reveal conviction through large stake increases. This article explains the implications whe...
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
A major fund recently disclosed a sizable sale of an AI marketing stock, a move that coincides with a 37% surge in th...
Investing often tempts us to cash in quick wins for the next big gain. This guide shows why you should think twice be...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A major fund reduced its TransAlta stake in Q4, sparking questions about the stock’s trajectory. This article explain...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...